ACTILLETS™ and TAP® Pellets
As a leader in novel and patient-friendly dose forms, our ACTILLETS™ microcrystalline cellulose (MCC) pellets and TAP® tartaric acid pellets are made to support oral formulations that demand precise control over drug release and dosing.
Two trusted brands. One powerful solution.
Through our partnership with Glatt and IPC, SPI Pharma exclusively markets CELLETS® microcrystalline cellulose (MCC) starter cores under the brand name ACTILLETS® in the U.S., Canada, Latin America, and Oceania. SPI provides formulators in our territories with access to the same trusted technology — paired with our expertise in oral dose development and local technical support.
Together with IPC’s proven pellet technologies, including TAP® tartaric acid pellets, we deliver a reliable foundation for innovative multiparticulate drug delivery systems, backed by both global expertise and regional availability.
Advanced Formulation
At SPI Pharma, we combine our deep expertise in excipient materials and oral dose development with microcrystalline cellulose (MCC) and tartaric acid pellets that deliver superior physical properties.
Both MCC and tartaric acid pellets are manufactured under GMP excipient standards, ensuring the consistent quality and reliability formulators expect.